{
    "organizations": [],
    "uuid": "0a24f917527a1d635252ace45b0f964a819a5ace",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ligand-pharma-says-co-sent-compute/brief-ligand-pharma-says-co-sent-computershare-as-rights-agent-under-glucagon-cvr-agreement-idUSFWN1RQ016",
    "ord_in_thread": 0,
    "title": "BRIEF-Ligand Pharma Says Co Sent Computershare, As Rights Agent Under Glucagon CVR Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13, 2018 / 10:26 AM / Updated 8 minutes ago BRIEF-Ligand Pharma Says Co Sent Computershare, As Rights Agent Under Glucagon CVR Agreement Reuters Staff 1 Min Read \nApril 13 (Reuters) - Ligand Pharmaceuticals Inc: \n* LIGAND PHARMACEUTICALS SAYS HOLDERS OF GLUCAGON CVRS ENTITLED TO RECEIVE PRO RATA $3.8 MILLION Source text: ( bit.ly/2JHfcOF ) Further company coverage:",
    "published": "2018-04-13T13:25:00.000+03:00",
    "crawled": "2018-04-13T13:36:13.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "pharma",
        "say",
        "co",
        "sent",
        "computershare",
        "right",
        "agent",
        "glucagon",
        "cvr",
        "agreement",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "ligand",
        "pharmaceutical",
        "inc",
        "ligand",
        "pharmaceutical",
        "say",
        "holder",
        "glucagon",
        "cvrs",
        "entitled",
        "receive",
        "pro",
        "rata",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}